← Back to Search

Reminder System for Postpartum Diabetes Screening in Gestational Diabetes

N/A
Waitlist Available
Research Sponsored by Thomas Jefferson University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial looked at whether a reminder system for postpartum diabetes screening would be effective in women who had gestational diabetes.

Who is the study for?
This trial is for women who had gestational diabetes during pregnancy, can communicate in English, and are at least 18 years old. It's not suitable for those who don't speak English or are younger than 18.Check my eligibility
What is being tested?
The study is testing whether a reminder system helps women with a history of gestational diabetes get screened for type 2 diabetes after giving birth.See study design
What are the potential side effects?
Since the intervention being studied is a reminder system rather than a medication or medical procedure, there are no direct side effects associated with it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postpartum Diabetes screening in GDM patients

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: active managementExperimental Treatment1 Intervention
Laboratoy test request given postpartum with phone reminder prior to test
Group II: Routine careActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Reminder
2022
N/A
~311170

Find a Location

Who is running the clinical trial?

Thomas Jefferson UniversityLead Sponsor
445 Previous Clinical Trials
145,636 Total Patients Enrolled

Media Library

Reminder Clinical Trial Eligibility Overview. Trial Name: NCT02520336 — N/A
Gestational Diabetes Research Study Groups: Routine care, active management
Gestational Diabetes Clinical Trial 2023: Reminder Highlights & Side Effects. Trial Name: NCT02520336 — N/A
Reminder 2023 Treatment Timeline for Medical Study. Trial Name: NCT02520336 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can I become a participant in this investigation?

"To be eligible for selection, potential candidates need to have diabetes or gestational diabetes and must lie within the 18-50 age bracket. Approximately 78 participants will eventually join this clinical trial."

Answered by AI

Are there available opportunities to join this research endeavor?

"Unfortunately, this medical trial is not presently open to enrolment. It was first posted on July 1st 2015 and the last update happened on August 7th of that same year. Fortunately, there are currently 1200 other studies recruiting patients for their respective experiments."

Answered by AI

Are participants aged 45 or over eligible to join this trial?

"This clinical trial requires participants aged 18 to 50 years old. Those under the age of consent have 188 separate trials available, while those above 65 can access 890 studies."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Postpartum Diabetes Screening in Women With Gestational Diabetes
2015. "Postpartum Diabetes Screening in Women With Gestational Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02520336.
All > Diabetes
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top